While in chronic myeloid leukemia (CML) the CXCR4 is downregulated, thereby promoting the mobilization of progenitor cells into blood, the receptor is highly expressed in breast cancer cells, favoring the migratory capacity of these cells. The gene discussed is CXCR4; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.